Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV000677723 | SCV000803877 | likely pathogenic | Early-onset generalized limb-onset dystonia | 2017-03-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001592856 | SCV001815050 | likely pathogenic | not provided | 2021-04-14 | criteria provided, single submitter | clinical testing | Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 45 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 31589614, 30877032, 26297380, 32399599, 30244176) |
Laboratory of Medical Genetics, |
RCV000677723 | SCV001976705 | pathogenic | Early-onset generalized limb-onset dystonia | 2021-10-01 | criteria provided, single submitter | clinical testing | PVS1, PP3, PP5 |
Institute of Human Genetics, |
RCV001250912 | SCV002765071 | likely pathogenic | Arthrogryposis multiplex congenita 5 | 2022-11-24 | criteria provided, single submitter | clinical testing | This variant was identified as homozygous._x000D_ Criteria applied: PVS1_STR, PM3, PM2_SUP |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV001250912 | SCV003806747 | pathogenic | Arthrogryposis multiplex congenita 5 | 2022-09-16 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PS4 supporting, PM2 supporting, PM3 supporting |
Broad Center for Mendelian Genomics, |
RCV001250912 | SCV003922270 | pathogenic | Arthrogryposis multiplex congenita 5 | 2023-05-02 | criteria provided, single submitter | curation | The homozygous p.Arg288Ter variant in TOR1A was identified by our study in one individual with arthrogryposis multiplex congenita. The p.Arg288Ter variant in TOR1A has been previously reported in 8 unrelated individuals with arthrogryposis multiplex congenita 15 (PMID: 34008892, PMID: 36757831, PMID: 32399599, PMID: 30244176, ClinVar SCV002765071.1) and segregated with disease in 2 affected siblings from one family (PMID: 32399599), but has been identified in 0.005% (6/113760) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP: rs760768475). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Of these 8 previously reported unrelated individuals (PMID: 34008892, PMID: 36757831, PMID: 32399599, PMID: 30244176, ClinVar SCV002765071.1), six were homozygotes (PMID: 34008892, PMID: 36757831, PMID: 32399599, PMID: 30244176, ClinVar SCV002765071.1) and two were compound heterozygotes who carried pathogenic variants in trans (PMID: 36757831, ClinVar Variation ID: 5180), which increases the likelihood that the p.Arg288Ter variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 559927) and has been interpreted as pathogenic or likely pathogenic by multiple submitters. This nonsense variant leads to a premature termination codon at position 288. This alteration occurs within the terminal 50 bases of the last exon and is more likely to escape nonsense mediated decay (NMD) and result in a truncated protein. Loss of function of the TOR1A gene is an established disease mechanism in autosomal recessive arthrogryposis multiplex congenita 15. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive arthrogryposis multiplex congenita 15. ACMG/AMP Criteria applied: PVS1_Strong, PM3_Strong, PM2_Supporting (Richards 2015). |
Ce |
RCV001592856 | SCV004010874 | likely pathogenic | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | TOR1A: PVS1:Strong, PM2 |
OMIM | RCV001250912 | SCV001426389 | pathogenic | Arthrogryposis multiplex congenita 5 | 2020-07-31 | no assertion criteria provided | literature only | |
Zotz- |
RCV001250912 | SCV004099348 | pathogenic | Arthrogryposis multiplex congenita 5 | 2023-10-30 | no assertion criteria provided | clinical testing |